Clinical Trial Update: Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51

View source ↗

Summary

Clinical trial update reporting long-term immunogenicity data for the Japanese Encephalitis vaccine IC51; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis

Drugs mentioned

• IC51 Japanese Encephalitis Vaccine (inactivated Japanese encephalitis vaccine IC51)

Snippet

Sponsor: Valneva Austria GmbH | Conditions: Japanese Encephalitis | Status: COMPLETED | Results posted: 2014-07-30